Neuroinflammatory processes play a crucial role in the progression of Alzheimer's Disease (AD) and dementia, contributing significantly to neuronal damage. In AD, the buildup of amyloid-beta plaques and tau tangles triggers immune responses in the brain, leading to chronic inflammation. Activated microglia, the brain's immune cells, release pro-inflammatory molecules, worsening neuronal dysfunction and cell death. This inflammatory cascade disrupts synaptic communication and accelerates cognitive decline by promoting the aggregation of pathological proteins.
Addressing neuroinflammation has become a promising avenue for therapeutic intervention in AD and dementia. Researchers are exploring drugs that can modulate immune responses or reduce inflammatory markers to mitigate excessive inflammation while preserving essential brain functions. Understanding these intricate inflammatory mechanisms is essential for developing effective treatments that could potentially slow or halt the progression of these debilitating neurodegenerative diseases.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China